UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000022762
Receipt No. R000026222
Scientific Title Risk factors of respiratory infectious complications after diagnostic bronchoscopy for the diagnosis of lung cancer
Date of disclosure of the study information 2016/07/01
Last modified on 2017/08/13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Risk factors of respiratory infectious complications after diagnostic bronchoscopy for the diagnosis of lung cancer
Acronym Risk factors of respiratory infectious complications after diagnostic bronchoscopy for the diagnosis of lung cancer
Scientific Title Risk factors of respiratory infectious complications after diagnostic bronchoscopy for the diagnosis of lung cancer
Scientific Title:Acronym Risk factors of respiratory infectious complications after diagnostic bronchoscopy for the diagnosis of lung cancer
Region
Japan

Condition
Condition Lung cancer
Classification by specialty
Pneumology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 to clarify the risk factors associated with respiratory infectious complications after diagnostic bronchoscopy
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes to elucidate the risf factors of respiratory infectious complications
Key secondary outcomes frequency of respiratory infectious complications

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients who will receive the bronchoscopy for the diagnosis of lung cancer
Key exclusion criteria patients who do not accept to be included in the observational study

patients for whom primary physicians do not think suitable for the clinical study
Target sample size 400

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Shiro Imokawa
Organization Iwata City Hospital
Division name Department of Respiratory Medicine
Zip code
Address 512-3 Okubo, Iwata, Shizuoka, 438-8550, Japan
TEL 0538-38-5000
Email fmrcw925@ybb.ne.jp

Public contact
Name of contact person
1st name
Middle name
Last name Shiro Imokawa
Organization Iwata City Hospital
Division name Department of Respiratory Medicine
Zip code
Address 512-3, Ookubo, Iwata, Shizuoka, 438-8550, Japan
TEL 0538-38-5000
Homepage URL
Email fmrcw925@ybb.ne.jp

Sponsor
Institute Iwata City Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 磐田市立総合病院(静岡県)

Other administrative information
Date of disclosure of the study information
2016 Year 07 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2016 Year 05 Month 01 Day
Date of IRB
Anticipated trial start date
2016 Year 07 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information frequency of respiratory infectious complications within 14 days after diagnostic bronchoscopy for the diagnosis of lung cancer and check the following:height, weight, BMI, TP, Alb, TG, TC, BS, HbA1c, liver function, renal function, arterial blood gas analysis, associateddiseases, the size, characteristic findings and location of the tumor,

Management information
Registered date
2016 Year 06 Month 15 Day
Last modified on
2017 Year 08 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026222

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.